Empagliflozin inhibits increased Na influx in atrial cardiomyocytes of patients with HFpEF
Sign Up to like & getrecommendations! Published in 2024 at "Cardiovascular Research"
DOI: 10.1093/cvr/cvae095
Abstract: Abstract Aims Heart failure with preserved ejection fraction (HFpEF) causes substantial morbidity and mortality. Importantly, atrial remodelling and atrial fibrillation are frequently observed in HFpEF. Sodium–glucose cotransporter 2 inhibitors (SGLT2i) have recently been shown to… read more here.
Keywords: atrial cardiomyocytes; increased influx; empagliflozin inhibits; cardiomyocytes patients ... See more keywords